“A high-level Pfizer manager went on record and said: if they had to choose between lowering prices in the US or not launching in France — they would not launch in France.” Christoffer Frendesen, EU correspondent for Dagens Pharma and
A coalition of 15 Democratic-led states filed a federal lawsuit Tuesday against the U.S. Department of Health and Human Services and Health Secretary Robert F. Kennedy Jr., seeking to reverse the CDC’s January 2026 decision to eliminate universal immunization recommendations
“If you take away funding from research and development, especially for diseases with pandemic potential, those programs will be delayed. We lose time, and some of that time can’t be recovered later with more funding.” Anand Ekambaram has spent more
Cytiva’s third Global Biopharma Index reports a decline in overall industry resilience amid ongoing talent shortages and increasing regulatory pressures. Every two years, Cytiva surveys 1,250 biopharma executives across 22 countries, asking them to rate the industry ecosystem on a
